Psychedelics for Brain Injury: A Mini-Review
An Erratum on
Psychedelics for Brain Injury: A Mini-Review
by Khan, S. M., Carter, G. T., Aggarwal, S. K., and Holland, J. (2021). Front. Neurol. 12:685085. doi: 10.3389/fneur.2021.685085
Due to a publisher error, the below junior reviewer was not included.
“Paolo Cardone, University of Liège, Belgium in collaboration with reviewer OG”
The publisher apologizes for this mistake. The original article has been updated.
Publisher's Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: psychedelics, neuroinflammation, neuroplasticity, stroke, brain injury, review
Citation: Frontiers Production Office (2021) Erratum: Psychedelics for Brain Injury: A Mini-Review. Front. Neurol. 12:772692. doi: 10.3389/fneur.2021.772692
Received: 08 September 2021; Accepted: 08 September 2021;
Published: 30 September 2021.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2021 Frontiers Production Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Production Office, production.office@frontiersin.org